Denali Therapeutics Files Prospectus for Sale of 29.29M Common Stock Shares
Friday, 22 March 2024, 20:17
Denali Therapeutics Prospectus: Offering 29.29M Common Stock Shares
Denali Therapeutics, ticker DNLI, has filed a prospectus for the offer and resale of up to 29,290,754 shares of common stock.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.